Immunomodulation by Bacterial Endotoxin

References

• Morrison D. C., Ryan J. L. Bacterial endotoxins and host immune responses. Adv. Immunol. 1979; 28: 293
   PubMedGoogle Scholar
• Morrison D. C. Bacterial endotoxins and pathogenesis. J. Infect. Dis. 1983; 5((Suppl. 4))S733
   Google Scholar
• Morrison D. C., Ryan J. L. Endotoxins and disease mechanisms. Annu. Rev. Med. 1987; 38: 417
   PubMed Web of Science ®Google Scholar
• Wilson M. E. Effects of bacterial endotoxins on neutrophil function. Rev. Infect. Dis. 1985; 7: 404
   PubMedGoogle Scholar
• Warren H. S., Chedid L. A. Strategies for the treatment of endotoxcmia: significance of the acute-phase response. Rev. Infect. Dis. 1987; 9((Suppl. 5))S630
   Google Scholar
• Hitchcock P. J., Leive L., Mäkel P. H., Rietschel E. T. Stritt-matter, W., and Morrison, D. C., Lipopolysaccharide nomenclature—past, present, and future. J. Bacteriol. 1986; 166: 699
   PubMed Web of Science ®Google Scholar
• Westphal O., Jann K. Bacterial lipopolysaccharide extraction with phenol-water and further application of the procedure. Methods in Carbohydrate Chemistry, R. L. Whistler. Academic Press, New York 1965; 83
   Google Scholar
• Rudbach J. A., Akiya F. I., Elin R. J., Hochstein H. D., Luoma M. K., Milner E. C. B., Milner K. C., Thomas K. R. Preparation of a national reference endotoxin. J. Clin. Microbiol. 1976; 3: 21
   PubMed Web of Science ®Google Scholar
• Galanos C., Lüderitz O. Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur. J. Biochem. 1975; 54: 603
   PubMedGoogle Scholar
• Boivin A., Mesrobeanu L. Recherches sur les antigènes so-matiques et sur les endotoxines des bactéries. I. Considerations gén-érales et exposé des techniques utilisies. Rev. Immunol. 1935; 1: 553
   Google Scholar
• Westphal O., Jann K., Himmelspach K. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog. Allergy 1983; 33: 9
   PubMedGoogle Scholar
• Nowotny A. Review of the molecular requirements of endotoxic actions. Rev. Infect. Dis. 1987; 9((Suppl. 5))S503
   Google Scholar
• Kotani S., Takada H., Tsujimoto M., Ogawa T., Takahashi I., Ikeda T., Otsuka K., et al. Synthetic lipid A with endotoxic and related biological activities comparable to those of natural lipid A from an Escherichia coli mutant. Infect. Immun. 1985; 49: 225
   PubMed Web of Science ®Google Scholar
• Takada H., Kotani S., Tsujimoto M., Ogawa T., Takahashi I., Harada K., Katsukawa C., et al. Immunopharmacological activities of a synthetic counterpart of a biosynthelic lipid A precursor molecule and of its analogs. Infect. Immun. 1985; 48: 291
   Web of Science ®Google Scholar
• Kotani S., Takada H., Tsujimoto M., Ogawa T., Harada K., Mori Y., Kawasaki A., et al. Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A. Infect. Immun. 1984; 45: 293
   PubMed Web of Science ®Google Scholar
• Johnson A. G., Tomai M., Solem L., Beck L., Ribi E. Characterization of a nontoxic monophosphoryl lipid A. Rev. Infect. Dis. 1987; 9((Suppl. 5))S512
   Google Scholar
• Madonna G. S., Peterson J. E., Ribi E. E., Vogel S. N. Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A. Infect. Immun. 1986; 52: 6
   PubMed Web of Science ®Google Scholar
• Rothman J., Johnson A. G., Friedman H., Kovats E., Pham P. H., Sanavi F., Nowotny A. M., Nowotny A. Biological effects of While-type polysaccharides of Gram-negative bacteria. J. Biol. Response Mod. 1985; 4: 169
   PubMedGoogle Scholar
• Friedman H., Blanchard D. K., Newton C., Klein T., Stewart W., II., Keier T., Nowotny A. Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures. J. Biol. Response Mod. 1987; 6: 664
   PubMedGoogle Scholar
• Lebbar S., Cavaillon J. M., Caroff M., Ledur A., Brade H., Sarfati R., Haeffner-Cavaillon N. Molecular requirement for mterleukin 1 induction by lipopolysaccharide-stimulated human mon-ocytes: involvement of the heptosyl-2-keto-3-deoxyocrulosonate region. Eur. J. Immunol. 1986; 16: 87
   PubMed Web of Science ®Google Scholar
• Nowotny A., Behling U. H., Chang H. L. Relation of structure to function in bacterial endotoxins. VIII. Biological activities in a polysaccharide-rich fraction. J. Immunol 1975; 15: 199
   Google Scholar
• Behling U. H., Campbell B., Chang C. M., Rumpf C., Nowotny A. Synthetic glycolipid adjuvants. J. Immunol. 1976; 117: 847
   PubMed Web of Science ®Google Scholar
• Nowotny A., Blanchard D. K., Newton C., Klein T., Stewart W., II, Szentivanyi A., Friedman H. Interferon induction by endotoxin-derived nontoxic polysaccharides. J. Interferon. Res. 1987; 7: 371
   PubMedGoogle Scholar
• Scibienski R. J. Immunologic properties of protein-lipopolysac-charide complexes. III. Role of carbohydrate in the adjuvant effect. Mol. Immunol. 1980; 17: 21
   PubMed Web of Science ®Google Scholar
• Morrison D. C., Kline L. F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J. Immunol. 1977; 118: 362
   PubMed Web of Science ®Google Scholar
• Girard R., Chaby R., Bordenave G. Mitogenic response of C3H/HeJ mouse lymphocytes to polyanionic polysaccharides obtained from Bordetella pertussis endotoxin and from other bacterial species. Infect. Immun. 1981; 31: 122
   PubMed Web of Science ®Google Scholar
• Williamson S. I., Wannemuehler M. J., Jirilio E., Pritchard D. G., Michalek S. M., McGhee J. R. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS. J. Immunol. 1984; 133: 2294
   PubMed Web of Science ®Google Scholar
• Haeffner-Cavaillon N., Cavaillon J.-M., Szabo L. Macro-phage-dependent polyclonal activation of splenocytes by Bordetella pertussis endotoxin and its isolated polysaccharide and lipid A regions. Cell. Immunol. 1982; 74: 1
   PubMed Web of Science ®Google Scholar
• Sultzer B. M., Castagna R. Inhibition of activated nonresponder C3H/HeJ lymphocytes by lipopolysaccharide endotoxin. Infect. Immun. 1988; 56: 3040
   PubMed Web of Science ®Google Scholar
• Flebbe L., Vukajlovich S. W., Morrison D. C. Immuno-stimulation of C3H/HeJ cells by chemotype lipopolysaccharide preparations. J. Immunol. 1989; 142: 642
   PubMed Web of Science ®Google Scholar
• Sultzer B. M., Goodman G. W. Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes. J. Exp. Med. 1976; 144: 821
   PubMed Web of Science ®Google Scholar
• Morrison D. C., Betz S. J., Jacobs D. M. Isolation of a lipid A bound polypeptide responsible for “LPS-initiated” mitogenesis of C3H/HeJ spleen cells. J. Exp. Med. 1976; 144: 840
   PubMed Web of Science ®Google Scholar
• Morrison D. C., Betz S. J. Chemical and biological properties of a protein-rich fraction of bacterial lipopolysaccharides. II. The in vitro rat peritoneal mast cell response. J. Immunol 1977; 119: 1790
   PubMed Web of Science ®Google Scholar
• Johns M. A., Sipe J. D., Melton L. B., Strom T. B., McCabe W. R. Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation. Infect. Immun. 1988; 56: 1593
   PubMed Web of Science ®Google Scholar
• Kurtz R. S., Berman D. T. Influence of cndotoxin-protein in immunoglobulin G isorype responses of mice to Brucella abortus lipopolysaccharide. Infect. Immun. 1986; 54: 728
   PubMed Web of Science ®Google Scholar
• Hogan M. M., Vogel S. N. Production of tumor necrosis factor by rIFN-γ-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins. J. Immunol 1988; 141: 4196
   PubMed Web of Science ®Google Scholar
• Burrell R., Rylander R. Comparative toxicity studies between bacterial lipopolysaccharide (endotoxin) and N-formyl-methionyl pep-tide as factors in the pathogenesis of byssinosis. J. Tox. Environ. Health 1985; 16: 607
   PubMed Web of Science ®Google Scholar
• Sung S. J., Jung L. K. L., Walters J. A., Chen W., Wang C. Y., Fu S. M. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J. Exp. Med. 1988; 168: 1539
   PubMed Web of Science ®Google Scholar
• Le J., Vilĉek J. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234
   PubMed Web of Science ®Google Scholar
• Goldberg D. I., Khoo J. C. Regulation of lipoprotein lipase secretion by mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 1987; 142: 1
   PubMed Web of Science ®Google Scholar
• White J. R., Chait A., Klebanoff S. J., Deeb S., Brunzell J. D. Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor. J. Lipid Res. 1988; 29: 1379
   PubMed Web of Science ®Google Scholar
• Vogel S. N., Kaufman E. N., Tate M. D., Neta R. Re-combinanl interleukin-1α and recombinant tumor necrosis factor a synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect. Immun. 1988; 56: 2650
   PubMed Web of Science ®Google Scholar
• Kiener P. A., Marek F., Rodgers G., Lin P.-F., Warr G., Desiderio J. Induction of tumor necrosis factor, IFN-γ, and acute lethality in mice by toxic and non-toxic forms of lipid A. J. Immunol. 1988; 141: 870
   PubMed Web of Science ®Google Scholar
• Cybulsky M. I., McComb D. J., Movat H. Z. Neutrophil leukocyte emigration induced by endotoxin. Mediator roles of interleukin 1 and tumor necrosis factor a. J. Immunol 1988; 140: 3144
   PubMed Web of Science ®Google Scholar
• Galanos C. 0. Physical state and biological activity of lipopolysac-charides. Toxicity and immunogenicity of the lipid A component. Z. Immun.-Forsch. 1975; 149: 214
   Google Scholar
• Vukajlovich S. W., Morrison D. C. Conversion of lipopoly-saccharides to molecular aggregates with reduced subunit heterogeneity: demonstration of LPS-responsiveness in “endotoxin-unresponsive” C3H/HeJ splenocytes. J. Immunol 1983; 130: 2804
   PubMed Web of Science ®Google Scholar
• Johne B., Myhrvold V., Morland B. Effects of endotoxins from Bacteroides intermedius and Escherichia coli on cytotoxic and lysosomal activity in peritoneal macrophages from endotoxin responder and low responder mouse strains. Acta Pathol. Microbiol. Immunol. Scand. 1987; 95: 85
   Google Scholar
• Tesh V. L., Duncan R. L., Jr., Morrison D. C. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacteria] killing. J. Immunol. 1986; 137: 1329
   PubMed Web of Science ®Google Scholar
• Tesh V. L., Morrison D. C. The physical-chemical characterization and biologic activity of serum released lipopolysaccharides. J. Immunol. 1988; 141: 3523
   PubMed Web of Science ®Google Scholar
• Goldman D. W., Enkel H., Gifford L. A., Chenoweth D. E., Rosenbaum J. T. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes. J. Immunol. 1986; 137: 1971
   PubMed Web of Science ®Google Scholar
• Reed D., Moore F. D. Recombinant human tumor necrosis factor increases granulocyte cell-surface complement receptor number. Arch. Surg. 1988; 123: 1333
   PubMedGoogle Scholar
• Strunk R. C., Whitehead A. S., Cole F. S. Pretranslational regulation of the third component of complement in human mononu-clear phagocytes by the lipid A portion of lipopolysaccharide. J. Clin Invest. 1985; 76: 985
   PubMed Web of Science ®Google Scholar
• Sutton M. B., Strunk R. C., Cole F. S. Regulation of the synthesis of the third component of complement and factor B in cord blood monocytes by lipopolysaccharide. J. Immunol. 1986; 136: 1366
   PubMed Web of Science ®Google Scholar
• Norn S., Jensen C., Dahl B. T., Stahl Skov P., Bák L., Permin H., Jarløv J. O., Sørensen H. Endotoxins release histamine by complement activation and potentiate bacteria-induced histamine release. Agents Actions 1986; 18: 149
   PubMedGoogle Scholar
• Okusawa S., Dinarello C. A., Yancey K. B., Endres S., Lawley T. J., Frank M. M., Burke J. F., Gelfand J. A. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-γ. J. Immunol. 1987; 139: 2635
   PubMed Web of Science ®Google Scholar
• van Vugt H., van Gool J., de Ridder L. Alpha 2 macrog-lobulin of the rat, an acute phase protein, mitigates the early course of endotoxin shock. Br. J. Exp. Pathol. 1986; 67: 313
   PubMedGoogle Scholar
• Baseler M. W., Burrell R. Differential toxicity of inhaled Gram-negative bacteria. Infect. Immun. 1983; 40: 133
   PubMed Web of Science ®Google Scholar
• Baseler M. W., Burrell R. Purification of haptoglobin and its effects on lymphocyte and alveolar macrophage responses. Inflammation 1983; 7: 387
   PubMed Web of Science ®Google Scholar
• Mathison J. C., Ulevitch R. J. Mediators involved in the expression of endotoxic activity. Surv. Synth. Path. Res. 1983; 1: 34
   Google Scholar
• Tesh V. L., Vukajlovich S. W., Morrison D. C. Endotoxin interactions with serum proteins. Relationship to biological activity. Prog. Clin. Biol. Res. 1988; 272: 47
   PubMedGoogle Scholar
• Tobias P. S., McAdam K. P. W. J., Ulevitch R. J. Interactions of bacterial lipopolysaccharide with acute-phase rabbit serum and amyloid A. J. Immunol. 1982; 128: 1420
   PubMed Web of Science ®Google Scholar
• Tobias P. S., McAdam K. P., Soldau K., Ulevitch R. J. Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum. Infect. Immun. 1985; 50: 73
   PubMed Web of Science ®Google Scholar
• Morel D. W., DiCorleto P. E., Chisolm G. M. Modulation of endotoxin-induced endothelial cell toxicity by low density lipoprotein. Lab. Invest. 1986; 55: 419
   PubMed Web of Science ®Google Scholar
• Navab M., Hough G. P., Van Lenten B. J., Berliner J. A., Fogelman A. M. Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. J. Clin. Invest. 1988; 81: 601
   PubMed Web of Science ®Google Scholar
• Warren H. S., Riveau G. R., de Deckker F. A., Chedid L. A. Control of endotoxin activity and interleukin-1 producbon through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor. Infect. Immun. 1988; 56: 204
   PubMed Web of Science ®Google Scholar
• Riveau G. R., Novitsky T. J., Roslansky P. F., Dinarello C. A., Warren H. S. Role of interleukin-1 augmenting serum neutralization of bacterial lipopolysaccharide. J. Clin. Microbiol. 1987; 25: 889
   PubMed Web of Science ®Google Scholar
• Cunha F. Q., Ferreira S. H. The release of a neutrophil chem-otactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. Eur. J. Pharmacol. 1986; 129: 65
   PubMed Web of Science ®Google Scholar
• Haeffner-Cavaillon N., Cavaillon J. M., Etievant M., Lebbar S., Szabo L. Specific binding of endotoxin to human monocytes and mouse macrophages: serum requirement. Cell. Immunol 1985; 91: 119
   PubMed Web of Science ®Google Scholar
• Lubinsky-Mink S., Munkenbeck P., Morrison D. C. Interactions of latex-insolubilized endotoxins with murine macrophages: phagocytic responses of endotoxin-responsive (C3HeB/FeJ) and -unresponsive (C3H/HeJ) macrophages in vitro. J. Retic. Soc. 1983; 33: 353
   PubMedGoogle Scholar
• Liang-Takasaki C.-J., Mäkelaˇ P. H., Leive L. Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J. Immunol. 1982; 128: 1229
   PubMed Web of Science ®Google Scholar
• Weir D. M., Blackwell C. C. Interaction of bacteria with the immune system. Clin. Lab. Immunol. 1983; 10: 1
   PubMedGoogle Scholar
• Larsen N. E., Sullivan R. Interaction between endotoxin and human monocytes: characteristics of the binding of 3H-labeled lipopolysaccharide and 51Cr-labeled lipid A before and after the induction of endotoxin tolerance. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 3491
   PubMed Web of Science ®Google Scholar
• Van Lenten B. J., Fogelman A. M., Seager J., Ribi E., Haberland M. E., Edwards P. A. Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J. Immunol 1985; 134: 3718
   PubMed Web of Science ®Google Scholar
• Ziegler H. K., Staffileno L. K., Wentworth P. Modulation of macrophage la-expression by lipopolysaccharide. I. Induction of Ia expression in vivo. J. Immunol. 1984; 133: 1825
   PubMed Web of Science ®Google Scholar
• Steeg P. S., Johnson H. M., Oppenheim J. J. Regulation of murine macrophage Ia expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J. Immunol. 1982; 129: 2402
   PubMed Web of Science ®Google Scholar
• Yem A. W., Parmely M. J. Modulation of Ia-like antigen expression and antigen-presenting activity of human monocytes by endoloxin and zymosan A. J. Immunol. 1981; 127: 2245
   PubMed Web of Science ®Google Scholar
• Leeuwenberg J. F., Van Damme J., Meager T., Jeunhomme T. M. A. A., Burman W. A. Effects of tumor necrosis factor on the interferon-γ-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur. J. Immunol. 1988; 18: 1469
   PubMed Web of Science ®Google Scholar
• Bismuth G., Duphot M., Theze J. LPS and specific T cell responses: interleukjn 1 (IL 1)-independent amplification of antigen-specific helper (Th) cell proliferation. J. Immunol. 1985; 134: 1415
   PubMed Web of Science ®Google Scholar
• Weiel J. E., Hamilton T. A., Adams D. O. LPS induces altered phosphate labeling of proteins in murine peritoneal macro-phages. J. Immunol. 1986; 136: 3012
   PubMed Web of Science ®Google Scholar
• Prpic V., Weiel J. E., Somers S. D., DiGuiseppi J., Gonias S. L., Pizzo S. V., Hamilton T. A., et al. Effects of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,5-bi-phosphate in murine peritoneal macrophages. J. Immunol. 1987; 139: 526
   PubMed Web of Science ®Google Scholar
• Shedlofsky S. I., Swim A. T., Robinson J. M., Gallicchio V. S., Cohen D. A., McClain C. J. Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice. Life Sci. 1987; 40: 2331
   PubMed Web of Science ®Google Scholar
• Goodwin J. S., Ceuppens J. Regulation of the immune response by prostaglandins. J. Clin. Immunol. 1983; 3: 295
   PubMed Web of Science ®Google Scholar
• D'Onofrio C., Paradisi F. The influence of bacterial exotoxins and endotoxins on the phagocytic activity of human macrophages in culture. Infection 1983; 11: 137
   PubMed Web of Science ®Google Scholar
• Aderem A. A., Cohen D. S., Wright S. D., Cohn Z. A. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J. Exp. Med. 1986; 164: 165
   PubMed Web of Science ®Google Scholar
• Schade U. F. The effect of endotoxin on the lipoxygenase-mediated conversion of exogenous and endogenous arachidonic acid in mouse peritoneal macrophages. Prostaglandins 1987; 34: 385
   PubMedGoogle Scholar
• Schade U. F. Involvement of lipoxygenases in the activation of mouse macrophages by endotoxin. Biochem. Biophys. Res. Commun. 1986; 138: 842
   PubMed Web of Science ®Google Scholar
• Mølvig J., Baek L., Christensen P., Manogue K. R., Vlassara H., Platz P., Nielsen L. S., Svejgaard A. Endotoxin-stim-ulated human monocyte secretion of interleukin 1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand. J. Immunol. 1988; 27: 705
   PubMed Web of Science ®Google Scholar
• Rylander R., Snella M. C. Endotoxins and the lung: cellular reactions and risk for disease. Prog. Allergy 1983; 33: 332
   PubMedGoogle Scholar
• Snella M. C. Production of a neutrophil chemotactic factor by endotoxin stimulated alveolar macrophages in vitro. Br. J. Exp. Pathol. 1986; 67: 801
   PubMedGoogle Scholar
• Rylander R., Beyer L. Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. Am. Rev. Resp. Dis. 1987; 135: 83
   PubMed Web of Science ®Google Scholar
• Christman J. W., Petras S. F., Hacker M., Absher P. M., Davis G. S. Alveolar macrophage function is selectively altered after endotoxemia in rats. Infect. Immun. 1988; 56: 1254
   PubMed Web of Science ®Google Scholar
• Eden E., Turino G. M. Interleukin-1 secretion by human alveolar macrophages stimulated with endoloxin is augmented by re-combinant immune (gamma) interferon. Am. Rev. Resp. Dis. 1986; 133: 455
   PubMedGoogle Scholar
• Janco R. L., Morris P. Serum augments the generation of monocyte procoagulant stimulated by bacterial lipopolysaccharide or chemotactic fragments of C5. Thromb. Res. 1983; 32: 73
   PubMed Web of Science ®Google Scholar
• Lando P. A., Edgington T. S. Lymphoid procoagulant response to bacterial endotoxin in the rat. Infect. Immun. 1985; 50: 660
   PubMed Web of Science ®Google Scholar
• Shands J. W., Jr. Lymphocyte collaboration is not required for the induction of murine macrophage procoagulant by endotoxin. Thromb. Res. 1987; 46: 271
   PubMed Web of Science ®Google Scholar
• Henry M. M., Moore J. N. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes. Circ. Shock 1988; 26: 297
   PubMedGoogle Scholar
• Moon D. K., Geczy C. L. Recombinant IFN-γ synergizes with lipopolysaccharide to induce macrophage membrane procoagulants. J. Immunol. 1988; 141: 1536
   PubMed Web of Science ®Google Scholar
• Dahinden C., Galanos C., Fehr J. Granuloctye activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J. Immunol. 1983; 130: 857
   PubMed Web of Science ®Google Scholar
• Madonna G. S., Vogel S. N. Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools. J. Immunol. 1985; 135: 3763
   PubMed Web of Science ®Google Scholar
• Madonna G. S., Vogel S. N. Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and sple-nectomized mice. Infect. Immun. 1986; 53: 707
   PubMed Web of Science ®Google Scholar
• Hartiala K. T, Langlois L., Goldstein I. M., Rosenbaum J. T. Endotoxin-induced selective dysfunction of rabbit polymor-phonuclear leukocytes in response to endogenous chemotactic factors. Infect. Immun. 1985; 50: 527
   PubMed Web of Science ®Google Scholar
• Bremm K. D., Konig W., Thelestam M., Alouf J. E. Modulation of granulocyte functions by bacterial exotoxin and endotoxins. Immunology 1987; 62: 363
   PubMed Web of Science ®Google Scholar
• Kosimar J. L., Cebra J. J. Monoclonal antibodies to Salmonella typhimurium and Escherichia coli lipopolysaccharides. Adv. Exp. Med. Biol. 1983; 162: 303
   PubMed Web of Science ®Google Scholar
• Kirkland T. N., Ziegler E. J., Tobias P., Ward D. C., Michalek S. M., McGbee J. R., Macher I., et al. Inhibition of lipopolysaccharide activation of 70Z/3 cells by anti-lipopolysaccharide antibodies. J. Immunol. 1988; 141: 3208
   PubMed Web of Science ®Google Scholar
• Zhang J., Liu Y. J., MacLennan I. C. M., Gray D., Lane P. J. L. B cell memory to thymus-independent antigens type 1 and type 2: the role of lipopolysaccharide in B memory induction. Eur. J. Immunol. 1988; 18: 1417
   PubMed Web of Science ®Google Scholar
• Vogel S. N., Hilfiker M. L., Caulfield M. J. Endotoxin-induced T lymphocyte proliferation. J. Immunol 1983; 130: 1774
   PubMed Web of Science ®Google Scholar
• Mukaida N., Kasahara T., Shioiri-Nakano K., Kawai T. Interleukin 2-dependent T cell line acquires responsiveness to phorbol myristate acetate and lipopolysaccharides in the course of long-term culture. Immunol. Commun. 1984; 13: 475
   PubMed Web of Science ®Google Scholar
• McGhee J. R., Farrar J. J., Michalek S. M., Mergenhagen S. E., Rosenstreich D. L. Cellular requirements for lipopolysaccharide adjuvanticiry. A role for both T lymphocytes and macrophages for in vitro responses to paniculate antigens. J. Exp. Med. 1979; 149: 793
   PubMed Web of Science ®Google Scholar
• Mita A., Ohta H., Mita T. in vivo activation of mouse spleen lymphocytes by lipid A in carrier-free form. Immunology 1982; 45: 333
   PubMed Web of Science ®Google Scholar
• Milner E. C. B., Rudbach J. A., Von Eschen K. B. Cellular responses to bacterial lipopolysaccharide: T cells recognize LPS determinants. Scand. J. Immunol. 1983; 18: 21
   PubMed Web of Science ®Google Scholar
• Wannemuehier M. J., Michalek S. M., Jirillo E., Williamson S. I., Hirasawa M., McGhee J. R. LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, poly-clonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice. J. Immunol. 1984; 133: 299
   PubMed Web of Science ®Google Scholar
• Lei M. G., Morrison D. C. Specific endotoxic lipopolysac-charide-binding proteins on murine splenocytes. I. Detection of lipo-polysaccharide-binding sites on splenocytes and splenocyte subpopulations. J. Immunol. 1988; 141: 996
   PubMed Web of Science ®Google Scholar
• Lei M. G., Morrison D. C. Specific endotoxic lipopolysac-charide-binding proteins on murine splenocytes. II. Membrane localization and binding characteristics. J. Immunol. 1988; 141: 1006
   PubMed Web of Science ®Google Scholar
• Monroe J. G., Cambier J. C. Level of mla expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle. J. Immunol. 1983; 130: 626
   PubMed Web of Science ®Google Scholar
• Jepbthab-Ocbola J., Urmson J., Farkas S., Halloran P. F. Regulation of MHC expression in vivo. Bacterial lipopolysac-charide induces class I and II MHC products in mouse tissues by a T-cell-independent, cyclosporine-sensiove mechanism. J. Immunol. 1988; 141: 792
   PubMed Web of Science ®Google Scholar
• Baker P. J., Hiernaux J. R., Fauntleroy M. B., Prescott B., Cantrell J. L., Rudbach J. A. Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A. Infect. Immun. 1988; 56: 1076
   PubMed Web of Science ®Google Scholar
• Büller H. R., ten Cate J. W., Shirk A., Thomas L. L. Validity of the endotoxin assay in post surgical patients. Prog. Clin. Biol. Res. 1985; 189: 405
   PubMedGoogle Scholar
• Lantz R. C., Birch K., Hinton D. E., Burrell R. Mor-phometric changes in the lung induced by inhaled baterial endotoxin. Exp. Mol. Pathol. 1985; 43: 305
   PubMed Web of Science ®Google Scholar
• Burrell R., Lantz R. C., Hinton D. E. Mediators of pulmonary injury induced by inhalation of bacterial endotoxin. Am. Rev. Resp. Dis. 1988; 137: 100
   PubMedGoogle Scholar
• Fischer J. J., Morey P. R., Sasser P. E., Foarde K. K. Environment influences levels of Gram-negative bacteria and endotoxin on cotton bracts. Am. Ind. Hyg. Assoc. J. 1982; 43: 290
   Web of Science ®Google Scholar
• Castellan R. M., Olenchock S. A., Kinsley K. B., Hankinson J. L. Inhaled endotoxin and decreased spirometric values. An exposure-response relation for cotton dust. N. Engl. J. Med. 1987; 317: 605
   PubMed Web of Science ®Google Scholar
• Remvig L., Enk C., Back L., Bendtzen K. Influence of endotoxin on production of leucocyte migration inhibition factor. I. J. Immunol. Meth. 1984; 72: 189
   PubMed Web of Science ®Google Scholar
• Chong K.-T., Huston M. Implications of endotoxin contamination in the evaluation of antibodies to lipopolysaccharides in a murine model of Gram-negative sepsis. J. Infect. Dis. 1987; 156: 713
   PubMed Web of Science ®Google Scholar
• Kornbluth R. S., Edgington T. S. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-a-mediated cellular cytotoxicity by endotoxin. J. Immunol. 1986; 137: 2585
   PubMed Web of Science ®Google Scholar
• McGhee J. R., Kiyono H., Alley C. D. Gut bacterial endotoxin: influence on gut-associated lymphoreticular tissue and host immune function. Surv. Immunol. Res. 1984; 3: 241
   PubMedGoogle Scholar